Free cash flow remains highly erratic, swinging from a 15.0% margin in 2025Q1 to a 3.3% margin in 2026Q2, reflecting ongoing capital intensity and working capital volatility.
| Metric | TTM | Sep'25 | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Sep'09 | Sep'08 | Sep'07 | Sep'06 | Sep'05 | Sep'04 | Sep'03 | Sep'02 | Sep'01 | Sep'00 | Sep'99 | Sep'98 | Sep'97 | Sep'96 |
|---|
| Cash from Operations | 61.01M | 72.18M | 49.74M | 5.83M | -466.05M | 149.86M | 37.87M | 90.9M | 73.96M | 96.22M | 39.55M | 43.73M | 53.78M | 54.39M | 36.04M | 87.65M | 27.87M | -56.49M | 13.66M | 72.87M | 65.19M | 31.11M | 8.86M | -48.33M | -55.66M | 20.68M | -13.18M | 5.5M | 1.8M | -2M | -2.1M |
| Operating CF Margin % | - | 12.16% | 8.67% | 0.88% | -83.9% | 29.17% | 9.75% | 11.64% | 11.71% | 18.24% | 7.06% | 7.91% | 11.14% | 12.88% | 6.94% | 12.74% | 4.7% | -25.83% | 2.59% | 9.8% | 10.73% | 6.71% | 1.65% | -14.07% | -18.29% | 5.42% | -4.1% | 5.29% | 1.8% | -2.31% | -2.32% |
| Operating CF Growth % | 34.29% | 45.11% | 752.64% | 101.25% | -410.99% | 295.76% | -58.34% | 22.89% | -23.13% | 143.32% | -9.56% | -18.69% | -1.12% | 50.92% | -58.88% | 214.47% | 149.34% | -513.69% | -81.26% | 11.78% | 109.53% | 251.37% | 118.32% | 13.17% | -369.08% | 256.97% | -339.6% | 205.56% | 190% | 4.76% | 70.83% |
| Net Income | -178.16M | -55.76M | -164.9M | -14.64M | 2.13B | 110.75M | 64.85M | 437.42M | 116.46M | 62.61M | -69.48M | 14.22M | 31.52M | -2.15M | 136.84M | 128.4M | 59.02M | -227.86M | -235.95M | 151.47M | 25.93M | -10.06M | 17.72M | -185.76M | -719.95M | -29.66M | 12.75M | -7.9M | -18.4M | 800K | 8.5M |
| Depreciation & Amortization | 56.81M | 61.21M | 90.74M | 85.58M | 53.7M | 65.33M | 65.5M | 54.45M | 37.43M | 28.15M | 28.05M | 25.16M | 23.46M | 24.16M | 21.62M | 17.25M | 18.42M | 25.86M | 34.54M | 32.8M | 33.9M | 17.19M | 18.38M | 31.81M | 38.03M | 45.26M | 30.21M | 10.4M | 8.1M | 4.8M | 3.1M |
| Stock-Based Compensation | 17.85M | 20.88M | 14.47M | 9.38M | 10.67M | 27.46M | 16.32M | 20.11M | 19.82M | 17.28M | 11.74M | 12.16M | 10.91M | 7.76M | 8.65M | 6.75M | 6.57M | 5.82M | 8.74M | 8.74M | 8.29M | 2.08M | 0 | 8.51M | 1.79M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -30.45M | -27.04M | -15.89M | -28.74M | 24.47M | -17.27M | -5.41M | -15.16M | -45.22M | 517K | 70.27M | -2.17M | -1.78M | -2.94M | -122.14M | -42.72M | -6.7M | 108.73M | -4.46M | -94.66M | -9.4M | -2.08M | 0 | -8.51M | 96.75M | -14.05M | -8.53M | -3M | -4.4M | -200K | -400K |
| Other Non-Cash Items | 230.62M | 95.73M | 122.28M | -16.71M | -2.62B | 14.8M | -90.72M | -411.12M | -7.94M | -11.64M | -1.27M | 3.45M | -24.39M | -515K | 14.22M | -383K | -215K | 212K | 208.94M | 7.21M | 5.28M | 468K | 9.9M | 81.42M | 492.13M | 1.13M | -372K | -100K | 200K | -100K | 100K |
| Working Capital Changes | -35.61M | -22.84M | 3.04M | -29.04M | -72.73M | -51.21M | -12.67M | 5.19M | -46.59M | -691K | 242K | -9.09M | 14.06M | 28.08M | -23.14M | -21.66M | -49.22M | 30.75M | 1.84M | -32.7M | 1.2M | 23.51M | -37.15M | 24.2M | 35.6M | 18.01M | -47.24M | 6.1M | 16.2M | -7.4M | -13.4M |
| Change in Receivables | -22.73M | -24.56M | -12.07M | 34.46M | -31.4M | -69.64M | -18.75M | -11.45M | -29.21M | -11.18M | -1.8M | -5.13M | 12.1M | 6.42M | -784K | 9.92M | -53.16M | 29.96M | -841K | -841K | -20.47M | 47.92M | 0 | 533K | 3.13M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -3.34M | -2.67M | 15.9M | 8.25M | -66.63M | -50.44M | -13.14M | -2.93M | -24.36M | -12.79M | 8.56M | -5.92M | 9.6M | 15.49M | 5.87M | -19.13M | -31.34M | 21.78M | -610K | -4.47M | -1.46M | 23.93M | -17.74M | 19.52M | 8.12M | 10.53M | -26.84M | 2M | 3.8M | -5.6M | -5M |
| Change in Payables | -5.21M | 1.04M | 9.2M | -14.71M | -3.93M | 30.97M | 792K | 4.7M | 5.46M | 7.85M | -5.14M | 8.36M | -11.92M | 3.12M | -11.18M | -15.1M | 39.35M | -10.95M | -14.76M | -14.76M | 22.51M | -14.2M | 0 | -3.96M | -2.49M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -105.52M | -90.46M | 224.74M | 431.38M | 1.47B | -146.35M | -22.74M | 211.31M | -148.47M | -54.19M | -10.87M | -17.64M | -17.8M | -7.15M | -21.04M | -84.25M | -29.21M | 6.25M | 16.77M | 80.97M | 19.07M | -27.64M | -70.75M | 43.59M | 10.21M | -153.74M | -141.91M | -10.6M | -4.6M | -8.4M | -11M |
| Capital Expenditures | -32.29M | -33.86M | -37.39M | -39.44M | -73.44M | -52.8M | -39.92M | -23.86M | -12.79M | -12.92M | -12.85M | -16.15M | -5.52M | -3.63M | -8.65M | -6.46M | -4.36M | -11.34M | -23.51M | -20.63M | -20.95M | -11.7M | -8.2M | -13.81M | -23.66M | -53.65M | -13.71M | -19.7M | -4.4M | -6.4M | -9.7M |
| CapEx % of Revenue | 5.41% | 5.7% | 6.52% | 5.93% | 13.22% | 10.28% | 10.28% | 3.06% | 2.02% | 2.45% | 2.29% | 2.92% | 1.14% | 0.86% | 1.67% | 0.94% | 0.74% | 5.18% | 4.47% | 2.78% | 3.45% | 2.52% | 1.53% | 4.02% | 7.78% | 14.06% | 4.27% | 18.96% | 4.4% | 7.41% | 10.73% |
| Acquisitions | -9.69M | 0 | 0 | -386.51M | 2.81B | -95.51M | -15.74M | 218.94M | -85.75M | -44.79M | -125.25M | -12.67M | 49.74M | -68.33M | -9.22M | -10.06M | 6.95M | 0 | -1M | 124K | -41.38M | 0 | 0 | 400K | -16.2M | -33.14M | -24.4M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 9M | 0 | 0 | 0 | -4M | 2M | -1M | 0 | 200K | 100K | 985K | 6K | 177K | 11.53M | -2.47M | -1.11M | 1.14M | 1.05M | 1.92M | 130.39M | 281K | 1.29M | 0 | 10.15M | 1.02M | -504K | -774K | 9.1M | -200K | -2M | -1.3M |
| Cash from Financing | -963K | -9.59M | -659.21M | -840.46M | -62.76M | -25.91M | -27.02M | -191.16M | 170.28M | -25.92M | -25.96M | -34.01M | -24.46M | -19.48M | -19.25M | -3.82M | 1.25M | 1.25M | -87.8M | -103.2M | -171.36M | 5.3M | 130.1M | 6.17M | 7.44M | 160.69M | 220.08M | 1.7M | -4M | 80.1M | -400K |
| Debt Issued (Net) | -939K | -985K | -783K | -578K | -50.11M | -1.99M | -2.1M | -165M | 196.05M | 0 | 366K | -8.83M | -239K | 0 | 0 | 0 | 0 | 0 | 0 | -1.74M | -175.01M | -11K | -98K | 34K | -587K | 152.7M | -5.83M | 1M | 2.5M | -100K | 800K |
| Equity Issued (Net) | 2.4M | 2.77M | -658.42M | -834.89M | 5.25M | 5.81M | 4.59M | 3.42M | 2.83M | 2.04M | 1.89M | 1.81M | 1.84M | 1.85M | 1.71M | 1.36M | 1.25M | 1.25M | -87.8M | -101.46M | 3.66M | 5.31M | 130.2M | 6.13M | 8.03M | 9.11M | 225.9M | 1.7M | 800K | 86.7M | 100K |
| Dividends Paid | 0 | 0 | 0 | 0 | -7.49M | -29.73M | -29.51M | -28.89M | -28.29M | -27.93M | -27.5M | -26.99M | -22.88M | -21.33M | -20.95M | -5.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100K |
| Share Repurchases | 0 | 0 | -661.7M | -838.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90.19M | -110.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -300K |
| Other Financing | -2.42M | -11.38M | 0 | -4.99M | -10.4M | 0 | 0 | -687K | -318K | -28K | -708K | 0 | -3.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.12M | 4K | 0 | -7.3M | -6.5M | 100K |
| Net Change in Cash | -39.58M | -24.3M | -363.06M | -357.25M | 755.96M | -17.19M | -2.65M | 107.46M | 96.09M | 16.54M | 4.36M | -13.39M | 11.14M | 28.33M | -4.19M | -990K | -162K | -50.28M | -57.96M | 52.46M | -86.69M | 9.18M | 68.28M | -298K | -34.94M | 26.6M | 64.84M | -3.1M | -7.1M | 80.1M | -400K |
| Free Cash Flow | 28.72M | 38.32M | 12.35M | -33.6M | -543.48M | 97.05M | -2.06M | 67.04M | 61.18M | 83.31M | 26.7M | 27.58M | 48.26M | 50.75M | 27.39M | 81.19M | 23.51M | -67.83M | -9.86M | 52.24M | 44.24M | 19.41M | 652K | -62.14M | -79.32M | -32.97M | -26.88M | -14.2M | -2.6M | -8.4M | -11.8M |
| FCF Margin % | 4.81% | 6.45% | 2.15% | -5.05% | -97.84% | 18.89% | -0.53% | 8.59% | 9.69% | 15.79% | 4.76% | 4.99% | 10% | 12.01% | 5.27% | 11.8% | 3.96% | -31.02% | -1.87% | 7.03% | 7.28% | 4.19% | 0.12% | -18.08% | -26.07% | -8.64% | -8.37% | -13.67% | -2.6% | -9.72% | -13.05% |
| FCF Growth % | -10.29% | 210.29% | 136.76% | 93.82% | -659.99% | 4815.84% | -103.07% | 9.58% | -26.56% | 212.02% | -3.2% | -42.85% | -4.91% | 85.34% | -66.27% | 245.39% | 134.66% | -588.1% | -118.87% | 18.09% | 127.91% | 2876.99% | 101.05% | 21.66% | -140.6% | -22.63% | -89.32% | -446.15% | 69.05% | 28.81% | 19.18% |
| FCF per Share | 0.62 | 0.84 | 0.23 | -0.51 | -7.26 | 1.30 | -0.03 | 0.93 | 0.86 | 1.18 | 0.39 | 0.40 | 0.71 | 0.77 | 0.42 | 1.25 | 0.37 | -1.08 | -0.15 | 0.71 | 0.61 | 0.43 | 0.01 | -1.69 | -3.07 | -1.83 | -1.56 | -1.27 | -0.25 | -1.07 | -1.37 |
| FCF Conversion (FCF/Net Income) | -0.16x | -1.29x | -0.30x | -0.41x | 1.09x | 1.35x | 0.58x | 3.15x | 0.63x | 1.54x | -0.57x | 3.07x | 12.06x | -24.55x | 0.26x | 0.68x | 0.47x | 0.25x | -0.06x | 1.08x | 2.51x | -3.84x | 0.33x | 0.26x | 0.08x | -0.70x | -1.03x | -0.70x | -0.10x | -2.50x | -0.25x |
| Interest Paid | 0 | 0 | 0 | 0 | 469K | 1.44M | 2.16M | 20.8M | 6.54M | 200K | 114K | 395K | 202K | 0 | 14K | 65K | 80K | 454K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 6.42M | 6.57M | 2.7M | 43.07M | 452.46M | 38.02M | 102.01M | 16.99M | 21.05M | 8.14M | 4.93M | 3.88M | 1.08M | 0 | 4.28M | 1.04M | 1.87M | 246K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biotech R&D spending volatility
As reported in financial statements, Azenta consistently generates positive operating cash flow despite recurring net losses, with the OCF/NI ratio frequently showing negative values, such as the -0.08 observed in 2026Q2, highlighting a significant divergence between accounting profitability and actual cash generation capabilities.
The persistent gap between net income and operating cash flow suggests that non-cash charges and accounting adjustments are heavily influencing the bottom line. Investors should monitor whether this cash-generative capacity is sustainable or if it relies on aggressive working capital management that may eventually reverse.
Based on recent SEC filings, Azenta's free cash flow margins remain highly erratic, fluctuating from a peak of 15.0% in 2025Q1 to a low of -3.6% in 2025Q4, indicating that the company has yet to establish a predictable or stable cash conversion trajectory.
This volatility suggests that the company's operational cash flow is highly sensitive to quarterly fluctuations in project-based revenue and timing of expenses. The inability to maintain consistent positive FCF margins warrants further investigation into the underlying cost structure and the effectiveness of the Ascend transformation program.
According to quarterly data, Azenta maintains a capital expenditure to revenue ratio typically ranging between 4% and 8%, reflecting the ongoing requirement to invest in and maintain its specialized, energy-intensive biorepository and laboratory infrastructure to support its service-based business model.
The consistent level of capital spending suggests that the company is in a phase of heavy asset maintenance rather than rapid expansion. This capital intensity may continue to act as a drag on free cash flow until the company can achieve higher utilization rates across its existing global footprint.
As evidenced by the $60.5 million outflow in 2025Q4 followed by a $15.4 million inflow in 2026Q1, Azenta's working capital dynamics appear highly unstable, suggesting that timing differences in customer collections and inventory management are creating significant quarterly noise in cash flow reporting.
These sharp swings in working capital may indicate challenges in managing the cash conversion cycle, particularly within the lumpy Products segment. Investors should monitor whether these fluctuations are merely timing issues or indicative of broader difficulties in aligning cash inflows with the company's operational commitments.
Based on historical figures, Azenta has transitioned from aggressive share repurchases, which saw over $660 million deployed in 2024, to a more conservative stance, suggesting a strategic pivot toward preserving cash for operational needs and potential future acquisitions following the divestiture of its semiconductor business.
The cessation of significant buybacks appears to reflect management's focus on internal margin improvement rather than financial engineering. Future capital deployment will likely be scrutinized for its ability to generate a return on invested capital that exceeds the company's current cost of capital.
Quick answers to the most common questions about buying AZTA stock.
Azenta, Inc. (AZTA) generated $72.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Azenta, Inc. (AZTA) generated $38.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Azenta, Inc. (AZTA) spent $33.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.